WuXi Advanced Therapies Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • WuXi Advanced Therapies's estimated annual revenue is currently $57.4M per year.
  • WuXi Advanced Therapies's estimated revenue per employee is $155,000

Employee Data

  • WuXi Advanced Therapies has 370 Employees.
  • WuXi Advanced Therapies grew their employee count by 7% last year.
  • WuXi Advanced Therapies currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

Accelerating the Progress and Time to Market of Bio-Based Drugs through Integrated Manufacturing and Laboratory Testing Services Our Story By leveraging platforms and integrated testing, the Advanced Therapies business unit of WuXi AppTec is a streamlined Contract Development and Manufacturing Organization (CDMO), pioneering the expedited development and commercialization of cell, gene, protein and viral-based therapies. This approach enables new biopharmaceuticals to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities of high-touch, multi-vendor production models. Our solutions help clients overcome challenges to commercialization, including process development, manufacturing capacity, analytical development, and raw materials management. Multiple, scale-able, enabling platforms integrate manufacturing, process development and testing capabilities to provide greater predictability and speed to clinic. Well positioned for growth, our investments in personnel and manufacturing continue to expand clinical and commercial capacities. Since 2004, WuXi AppTec has supported Advanced Therapy programs with an extensive infrastructure of state-of-the-art, GMP-compliant facilities, providing centers of excellence for manufacturing and testing. Our Vision To significantly contribute to the growth of Advanced Therapies by accelerating and transforming development and manufacturing through our enabling platforms and technologies to the benefit of patients worldwide.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







WuXi Advanced Therapies News

09/03/2019 - Going Viral: The Next Generation of AAV Vectors

The safe delivery of genetic cargo has preoccupied gene therapy for at .... the Chinese company WuXi Advanced Therapies, Novasep, Vigene ...

08/22/2019 - The Cell Therapy Manufacturing Market is Projected to Reach ...

Given the commercial success of multiple cell therapies, such as .... Biomanufacturing; WuXi Advanced Therapies, a subsidiary of WuXi AppTec.

09/03/2019 - WuXi AppTec Launches DNA Encoded Library (DEL) Service ...

3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of ... to advance discoveries and deliver groundbreaking treatments to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing

WuXi Advanced Therapies Executive Hires

2009-05-06Hao ZhouVP FinanceArticle
2010-05-13Hao ZhouChief Financial OfficerArticle
2014-02-27Dr. Hua MuHead Product Development Service/Partnership Business UnitArticle

WuXi Advanced Therapies Acquisitions

DateCompany NameAmountNotesReference
2017-10-18ResearchPoint GlobalArticle

WuXi Advanced Therapies Hiring Plans

DateNumber of EmployeesLocationReference
2018-04-20200New Jersey.Article